Pharmacielo Ltd (PCLO) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.236x

Based on the latest financial reports, Pharmacielo Ltd (PCLO) has a cash flow conversion efficiency ratio of 0.236x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-3.53 Million ≈ $-2.55 Million USD) by net assets (CA$-14.94 Million ≈ $-10.81 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Pharmacielo Ltd to measure how much of total assets are equity-financed.

Pharmacielo Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Pharmacielo Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Pharmacielo Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Pharmacielo Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Pharmacielo Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Excite Technology Services Ltd AU:EXT	4.205x
Noida Toll Bridge Company Limited NSE:NOIDATOLL	-1.598x
Techgen Metals Ltd AU:TG1	-0.102x
Ely Gold Royalties Inc V:ELY	-0.050x
ReTo Eco-Solutions Inc NASDAQ:RETO	-0.111x
Techstep ASA OL:TECH	0.098x
Max Resource Corp V:MAX	-0.058x
Saxlund Group AB ST:SAXG	-0.028x

Annual Cash Flow Conversion Efficiency for Pharmacielo Ltd (2016–2024)

The table below shows the annual cash flow conversion efficiency of Pharmacielo Ltd from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see Pharmacielo Ltd stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CA$-7.52 Million ≈ $-5.44 Million	CA$-1.97 Million ≈ $-1.42 Million	0.262x	-91.45%
2023-12-31	CA$-1.68 Million ≈ $-1.22 Million	CA$-5.15 Million ≈ $-3.73 Million	3.066x	+301.87%
2022-12-31	CA$6.39 Million ≈ $4.62 Million	CA$-9.71 Million ≈ $-7.02 Million	-1.519x	-46.22%
2021-12-31	CA$19.33 Million ≈ $13.98 Million	CA$-20.07 Million ≈ $-14.52 Million	-1.039x	-20.82%
2020-12-31	CA$26.25 Million ≈ $18.99 Million	CA$-22.56 Million ≈ $-16.32 Million	-0.860x	-55.33%
2019-12-31	CA$45.47 Million ≈ $32.89 Million	CA$-25.16 Million ≈ $-18.20 Million	-0.553x	-30.88%
2018-12-31	CA$185.55K ≈ $134.23K	CA$-78.47K ≈ $-56.76K	-0.423x	+98.98%
2017-12-31	CA$91.02K ≈ $65.84K	CA$-3.79 Million ≈ $-2.74 Million	-41.637x	-12744.15%
2016-12-31	CA$9.57 Million ≈ $6.92 Million	CA$-3.10 Million ≈ $-2.24 Million	-0.324x	--

About Pharmacielo Ltd

V:PCLO Canada Drug Manufacturers - Specialty & Generic

Market Cap

$8.84 Million

CA$12.22 Million CAD

Market Cap Rank

#27334 Global

#1146 in Canada

Share Price

CA$0.07

Change (1 day)

+8.33%

52-Week Range

CA$0.04 - CA$0.14

All Time High

CA$11.02